Hara Levy, MD, MMSc
Pediatric pulmonologist, Children's Hospital of Wisconsin; associate professor, Pediatrics, the Medical College of Wisconsin.
Genetic modifiers for cystic fibrosis, correlation between genotype and varied phenotypic expressions in CF patients, CF newborn screening.
Medical degree, Medical College of Wisconsin, Milwaukee, 1991; Intern, Internal Medicine and Pediatrics, Combined Program in Internal Medicine and Pediatrics, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, 1992; resident, Internal Medicine and Pediatrics, Combined Program in Internal Medicine and Pediatrics, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, 1996; Pediatric Cardiology fellowship, Children's Hospital, Philadelphia, 1997; Pediatric Scientist Development Training program fellow, Genetics, Harvard Medical School, Boston, 2000; Clinical fellow, Pulmonary Medicine, Pediatric Pulmonology, Children's Hospital, Boston, MA, 2001; M.M.Sc. (Medical Sciences), Harvard Medical School, Boston, 2003.
Diplomate, National Board of Medical Examiners, 1992-present; diplomate, Americal Board of Internal Medicine-Internal Medicine, 2007; diplomate, American Board of Pediatrics, 2000-present; member, American College of Physicians - American Society of Internal Medicine, 2001-present; fellow, American Academy of Pediatrics, 2005-present; American Board of Pediatrics, Sub-Board certification, Pediatric Pulmonology, 2010-present.
Pediatric Scientist Development Training Fellowship Award, Harvard Medical School, Boston, 2000; Clinical Fellowship Award, Cystic Fibrosis Foundation, Children's Hospital, Boston, 2001; Glaser Foundation Research Fellowship, Children's Hospital, Boston, 2003; Pediatric-Extramural, National Institutes of Health Loan Repayment Program, Children's Hospital, Boston, 2007; American Thoracic Society Unrestricted Research Funding Award, Children's Hospital, Boston, 2007.
Wisconsin Medical License, 2007-2011; Massachusetts Medical License, 1997-2012.
- Baker MW, Gross M, Hoffman G, Rock M, Levy H and Farrell PM. Optimal DNA Tier for the IRT/DNA Algorithm: Lessons Learned from the CFTR Mutation Results in Wisconsin's 1994-2008 Cystic Fibrosis Newborn Screening Program. JCF. 2011 Mar 7; PMID: 21388895.
- Jadin SA, Wu GS, Zhang Z, Shoff SM, Tippets BM, Farrell PM, Miller T, Rock MJ, Levy H and Lai HJ. Growth and Pulmonary Outcomes During the first Two Years of Life of Breastfed and Formula-fed Infants Diagnosed with Cystic Fibrosis through the Wisconsin Routine Newborn Screening Program. The American Journal of Clinical Nutrition. 2011 May; 93(5):1038-47. Epub 2011 Mar 23. PMID: 21430114; PMC3076655.
- Rock MJ, Levy H, Zaleski C, Farrell PM. Factors Accounting for a Missed Diagnosis of Cystic Fibrosis After Newborn Screening. Pediatric Pulmonology. 2011; 46(12):1166-74. PMID: 22081556.
- Sebro R*, Levy H*, Schneck K, Dimmock D, Raby BA, Cannon CL, Broeckel U and Risch NJ. Cystic Fibrosis Mutations for F508del Compound Heterozygotes Predict Sweat Chloride Levels and Pancreatic Sufficiency. Clin Genet. 2011 Oct 28, doi: 10.1111/j.1399. 0004.2011.01804.x. [Epub ahead of print]. PMID: 22035343 (*indicates co-first authorship).
- Baughn JM, Quasney MW, Simpson P, Merchant D, Li SH, Levy H, Dahmer MK. Association of CFTR Gene Variants with Acute Lung Injury in African American Children with Pneumonia. Critical Care Medicine. 2012, in press.
- Levy H, Wang X, Kaldunski M, Jia S, Kramer J, Pavletich SJ, Reske M, Gessel T, Yassai M, Quasney MW, Dahmer MK, Gorski J, Hessner MJ. Transcriptional Signatures as a Disease-specific and Predictive Inflammatory Biomarker. Genes and Immunity. 2012; submitted.
- Integration of Genomics with Genetics-Molecular Phenotypes for CF Lung Disease, National Institutes of Health/Office of the Director, principal investigator.
- Family Gene Polymorphisms and Susceptibility to P. aeruginosa in CF Patients, National Institutes of Health/National Heart, Lung and Blood Institute, principal investigator.
- Malnutrition and Lung Disease in Cystic Fibrosis, National Institutes of Health/National Institute of Diabetes and Digestive Kidney Disease (NIDDK), co-principal investigator.
- A Molecular signature Identifies as IL1RN Response in Cystic Fibrosis (CF) Lung Disease, Genentech, principal investigator.
Medical College of Wisconsin
TBRC/CRI 2nd Floor
8701 Watertown Plank Road
Milwaukee, WI 53226
Phone: (414) 955-2379
Fax: (414) 955-6538
Investigator in the areas of: